Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

12 Connected Health

Seizing the opportunities in a new era of care

Havas Lynx

Sanofi reception

Sanofi and Boehringer in $20bn asset swap negotiations

Want to exchange their consumer health and veterinary interests

- PMLiVE

FDA panel rejects cardiovascular outcomes claim for Vytorin

Merck & Co fail to convince regulator's advisors

- PMLiVE

Chase Pharmaceuticals appoints former Allergan president

Douglas Ingram joins as chief executive officer

- PMLiVE

Money-back guarantee

Why doesn’t this apply to the drugs and devices that we use?

- PMLiVE

Another lost decade for research?

What does the patent landscape look like for antibiotics, vaccines and orphan drugs?

- PMLiVE

It’s time for pharma companies to become household names

And then the sector can become meaningful to the lives of ‘ordinary’ people

- PMLiVE

Less is more: how risk-based monitoring is changing trials

A quality risk management approach is one of the biggest drivers for change in clinical research

- PMLiVE

AZ confirms interest in Acerta takeover

Possible acquisition of Netherlands-based cancer drug developer may be worth more than $5bn

- PMLiVE

NICE backs Xtandi but turns down Zytiga

Astellas and Medivation's pre-chemotherapy prostate cancer drug receives support

Roche Basel Switzerland

Roche’s lung cancer drug Alecensa gets FDA OK

Wins accelerated US approval for non-small cell lung cancer

Centralized marketing with local market relevance: The big challenge for Pharma HQ marketers

There are good reasons for wanting to centralize and control marketing content: it reduces duplication of work, saves money and time, and also ensures a consistent level of quality. With...

Anthill Agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links